RIV Capital Inc.

RIV Capital Inc.

Share

RIV Capital announces shareholder approval of business combination with Cansortium 08/28/2024

We're pleased to announce that RIV shareholders have voted in favour to approve the previously announced proposed business combination with Cansortium Inc. Approximately 98.8% of the votes eligible to be cast at the RIV Meeting were voted in favor of the Arrangement Resolution: https://www.rivcapital.com/newsroom/company-news/news-details/2024/08/28/riv-capital-announces-shareholder-approval-of-business-combination-with-cansortium-and-cansortium-announces-shareholder-approval-of-the-amendment-proposal

We also reported our financial results for the quarter ended June 30, 2024. View our results, and catch up on news: https://www.rivcapital.com/newsroom/company-news/news-details/2024/08/28/riv-capital-reports-financial-results-for-the-second-quarter-ended-june-30-2024

RIV Capital announces shareholder approval of business combination with Cansortium Holders of Class A common shares of RIV Capital voted in favor of a special resolution to approve the previously announced proposed business combination with Cansortium Inc

Photos from RIV Capital Inc.'s post 05/30/2024

We are pleased to announce that we have entered into a definitive agreement with Cansortium, a vertically integrated, multi-state company with operations in Florida, Pennsylvania, and Texas.

Info: https://www.rivcapital.com/newsroom/company-news/news-details/2024/05/30/cansortium-and-riv-capital-announce-business-combination

RIV Capital reports results for the quarter and transition period ended Dec 31, 2023 04/29/2024

View our latest financial results and catch up on news: https://www.rivcapital.com/newsroom/company-news/news-details/2024/04/29/riv-capital-reports-financial-results-for-the-fiscal-quarter-and-nine-month-transition-period-ended-december-31-2023

During the quarter, Etain Health received New York Cannabis Control Board approval to be one of the first six registered organizations to officially transition to an adult-use license in New York, and Etain has commenced both adult-use retail and wholesale sales.

RIV Capital reports results for the quarter and transition period ended Dec 31, 2023 Ended the year with $81.9 million of cash to support operationalization of New York market and growth initiatives

02/14/2024

Etain Health has opened its first co-located adult-use and medical dispensary in White Plains, New York!
Learn more: https://www.rivcapital.com/newsroom/company-news/news-details/2024/02/14/riv-capital-and-etain-open-first-new-york-adult-use-dispensary-in-white-plains

RIV Capital sets date for financial results for fiscal quarter ended September 30, 2023 11/15/2023

RIV Capital will report its financial results for the three and six months ended September 30, 2023 before markets open on Wednesday, November 29, 2023.

RIV Capital sets date for financial results for fiscal quarter ended September 30, 2023 RIV Capital Inc. will report its financial results for the three and six months ended September 30, 2023 before markets open on Wednesday, November 29, 2023.

Want your practice to be the top-listed Clinic in Toronto?
Click here to claim your Sponsored Listing.

Address


Suite 2504
Toronto, ON
M5H3Y2